BioCentury
ARTICLE | Clinical News

Anti CD-22 antibodies regulatory update

February 12, 2001 8:00 AM UTC

IMMU received U.S. Patent No. 6,183,744 covering use of anti- CD22 antibodies to treat B cell lymphomas. ...